Longitudinal Progression Markers of Parkinson’s Disease: Current View on Structural Imaging

被引:0
作者
Jing Yang
Roxana G. Burciu
David E. Vaillancourt
机构
[1] West China Hospital of Sichuan University,Department of Neurology
[2] University of Florida,Department of Applied Physiology and Kinesiology
[3] University of Delaware,Department of Kinesiology and Applied Physiology, College of Health Sciences
[4] University of Florida,Department of Applied Physiology and Kinesiology, Department of Neurology, Department of Biomedical Engineering
来源
Current Neurology and Neuroscience Reports | 2018年 / 18卷
关键词
Parkinson’s disease; Progression; Biomarkers; Structural MRI; Diffusion-weighted MRI; Free-water;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 514 条
[1]  
Pringsheim T(2014)The prevalence of Parkinson’s disease: a systematic review and meta-analysis Mov Disord 29 1583-1590
[2]  
Jette N(2015)Parkinson’s disease Lancet (London, England) 386 896-912
[3]  
Frolkis A(1973)Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations J Neurol Sci 20 415-455
[4]  
Steeves TD(2010)Clinical progression in Parkinson disease and the neurobiology of axons Ann Neurol 67 715-725
[5]  
Kalia LV(2003)Parkinson’s disease: mechanisms and models Neuron 39 889-909
[6]  
Lang AE(2003)Staging of brain pathology related to sporadic Parkinson’s disease Neurobiol Aging 24 197-211
[7]  
Bernheimer H(2000)Voxel-based morphometry--the methods NeuroImage 11 805-821
[8]  
Birkmayer W(2018)Long-term effects of cognitive rehabilitation on brain, functional outcome and cognition in Parkinson’s disease Eur J Neurol 25 5-12
[9]  
Hornykiewicz O(2017)Regional volumetric change in Parkinson’s disease with cognitive decline J Neurol Sci 373 88-94
[10]  
Jellinger K(2010)Differential progression of brain atrophy in Parkinson’s disease with and without visual hallucinations J Neurol Neurosurg Psychiatry 81 650-657